Element Biosciences

Element Biosciences develops disruptive DNA sequencing and multi-omics technology for research markets. Their innovative platform, AVITI, offers high-quality, affordable data and an improved user experience, aiming to democratize access to advanced biological tools. The company's goal is to accelerate scientific discoveries and advance precision medicine.

Funding Round: Series D

Funding Amount: $277M

Date: 11-Jul-2024

Investors: Wellington Management, Samsung Electronics, Fidelity, Foresite Capital, funds and accounts advised by T. Rowe Price Associates, Inc, Venrock

Markets: Biotechnology, Genomics, Life Science, Precision Medicine, Genetics, Health Diagnostics

HQ: San Diego, California, United States

Founded: 2017

Website: https://www.elementbiosciences.com

LinkedIn: https://www.linkedin.com/company/elembio

Twitter: https://twitter.com/ElemBio

Instagram:

Facebook: https://www.facebook.com/elementbiosciences/

Crunchbase: https://www.crunchbase.com/organization/element-bioscience

Pitchbook: